Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Cancer

Figure 1

From: Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

Figure 1

Immunoaffinity analysis of human recombinant TK1 and serum TK1. (A) Results from the immunoaffinity/Western blotting analysis of purified recombinant human TK1 and the 26 kDa band relative intensity (arbitrary units, A.U.) used as a standard. (B) Examples of results of the immunoaffinity/Western blotting analysis of sera from blood donors, (C) MDS patients, (D) breast cancer, (E) or prostate cancer patients.

Back to article page